PBMWW

PSYENCE BIOMEDICAL LTD

• TipRanks·1d ago

  Psychedelic: AtaiBeckley reports publication of BPL-003 study results

• Benzinga·2d ago

  Psyence BioMed Expands Australian Clinical Network To 5 Sites For Psilocybin Phase IIb Trial

• Reuters·2d ago

  PSYENCE BIOMEDICAL LTD - EXPANDS AUSTRALIAN CLINICAL SITE NETWORK TO FIVE SITES

• Reuters·2d ago

  Psyence BioMed expands Australia clinical trial network to five sites for NPX-5 program

• Reuters·03/26 06:24

  Psyence Group; GoldCoast private placement raises $2.78 million on $0.85 shares

• Reuters·03/18 07:20

  Psyence Group says GoldCoast raises CAD 5.83 million in financing tied to proposed amalgamation

• Reuters·03/11 13:25

  Psyence BioMed Plans to Advance Vertically Integrated Platform and Product and Clinical Development Program, Targeting Phase IIb Trial Execution and Regulatory Readiness

• Reuters·03/11 13:15

  Psyence Biomedical appoints Sashank Pillay to board after Seth Feuerstein resigns

• Reuters·03/11 13:15

  CORPORATE UPDATE: PSYENCE BIOMED ADVANCES VERTICALLY INTEGRATED PHARMACEUTICAL PLATFORM FOLLOWING PSYLABS EXPORT MILESTONE

• Benzinga·03/06 12:05

  12 Health Care Stocks Moving In Friday's Pre-Market Session

• TipRanks·03/05 15:15

  Psychedelic: Helus Pharma reports HLP004 Phase 2 signal detection study results

• TipRanks·03/03 14:22

  Psyence Biomedical announces export of psilocybin to Australia

• Benzinga·03/03 14:17

  Psyence Biomedical Announces Export Of Fully GMP-Compliant Manufactured Psilocybin Product NPX-5 To Australia

• Reuters·03/03 14:15

  BRIEF-Psyence Biomed Announces Export Of Gmp-Manufactured Natural Psilocybin (Npx-5) To Australia For Ongoing Phase Iib Clinical Trial

• Reuters·03/03 14:15

  Psyence BioMed Exports GMP-Manufactured Natural Psilocybin NPX-5 to Australia for Phase IIb Trial